Pulmonx Corp Quarterly Share-based Payment Arrangement, Expense in USD from Q3 2019 to Q3 2024

Taxonomy & unit
us-gaap: USD
Description
Amount of expense for award under share-based payment arrangement. Excludes amount capitalized.
Summary
Pulmonx Corp quarterly/annual Share-based Payment Arrangement, Expense history and growth rate from Q3 2019 to Q3 2024.
  • Pulmonx Corp Share-based Payment Arrangement, Expense for the quarter ending September 30, 2024 was $5.84M, a 2.73% decline year-over-year.
  • Pulmonx Corp Share-based Payment Arrangement, Expense for the twelve months ending September 30, 2024 was $23M, a 11% increase year-over-year.
  • Pulmonx Corp annual Share-based Payment Arrangement, Expense for 2023 was $22.1M, a 34.4% increase from 2022.
  • Pulmonx Corp annual Share-based Payment Arrangement, Expense for 2022 was $16.4M, a 56.2% increase from 2021.
  • Pulmonx Corp annual Share-based Payment Arrangement, Expense for 2021 was $10.5M, a 229% increase from 2020.
Share-based Payment Arrangement, Expense, Trailing 12 Months (USD)
Share-based Payment Arrangement, Expense, Quarterly (USD)
Share-based Payment Arrangement, Expense, YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q3 2024 $23M $5.84M -$164K -2.73% Jul 1, 2024 Sep 30, 2024 10-Q 2024-11-01
Q2 2024 $23.2M $5.92M +$58K +0.99% Apr 1, 2024 Jun 30, 2024 10-Q 2024-08-02
Q1 2024 $23.1M $5.67M +$1.04M +22.3% Jan 1, 2024 Mar 31, 2024 10-Q 2024-05-03
Q4 2023 $22.1M $5.6M +$1.35M +31.8% Oct 1, 2023 Dec 31, 2023 10-K 2024-02-27
Q3 2023 $20.8M $6M +$1.7M +39.5% Jul 1, 2023 Sep 30, 2023 10-Q 2024-11-01
Q2 2023 $19M $5.86M +$1.48M +33.7% Apr 1, 2023 Jun 30, 2023 10-Q 2024-08-02
Q1 2023 $17.6M $4.64M +$1.13M +32% Jan 1, 2023 Mar 31, 2023 10-Q 2024-05-03
Q4 2022 $16.4M $4.25M +$1.24M +41% Oct 1, 2022 Dec 31, 2022 10-K 2024-02-27
Q3 2022 $15.2M $4.3M +$1.36M +46.4% Jul 1, 2022 Sep 30, 2022 10-Q 2023-11-03
Q2 2022 $13.8M $4.38M +$2.07M +89.6% Apr 1, 2022 Jun 30, 2022 10-Q 2023-08-04
Q1 2022 $11.8M $3.51M +$1.25M +54.9% Jan 1, 2022 Mar 31, 2022 10-Q 2023-05-08
Q4 2021 $10.5M $3.01M +$701K +30.3% Oct 1, 2021 Dec 31, 2021 10-K 2023-03-01
Q3 2021 $9.83M $2.94M +$2.42M +467% Jul 1, 2021 Sep 30, 2021 10-Q 2022-11-08
Q2 2021 $7.41M $2.31M +$2.15M +1354% Apr 1, 2021 Jun 30, 2021 10-Q 2022-08-08
Q1 2021 $5.26M $2.27M +$2.06M +985% Jan 1, 2021 Mar 31, 2021 10-Q 2022-05-09
Q4 2020 $3.2M $2.31M Oct 1, 2020 Dec 31, 2020 10-K 2022-03-01
Q3 2020 $518K +$446K +619% Jul 1, 2020 Sep 30, 2020 10-Q 2021-11-09
Q2 2020 $159K Apr 1, 2020 Jun 30, 2020 10-Q 2021-08-10
Q1 2020 $209K Jan 1, 2020 Mar 31, 2020 10-Q 2021-05-12
Q3 2019 $72K Jul 1, 2019 Sep 30, 2019 10-Q 2020-11-13
* An asterisk sign (*) next to the value indicates that the value is likely invalid.